Listen to an audio version of the story.
On a recent Saturday, a group of masked neighbors living on Buena Vista Street in Midtown Memphis congregate at distance, of course on Jeff Warren’s front yard.
“We hope to be the Buena Vista model,” says Warren, who is a medical doctor and a member of the City Council.
He means a model for what’s called assurance or surveillance testing. Since mid-November, Warren has been setting up a weekly, mini COVID-19 testing operation in front of his house. Here, the tight-knit residents of the neighborhood along with their co-mingling children test for the virus as a group. It’s a strategy to catch asymptomatic carriers of the virus and hopefully reduce spread.
Knoxville Biz Ticker: Tennessee Governor Bill Lee, State Leaders and Comcast address telehealth and digital equity for older adults
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
The Next Dean of the College of Nursing and Health Sciences at the University of Vermont : The Journal of Blacks in Higher Education
jbhe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jbhe.com Daily Mail and Mail on Sunday newspapers.
Preclinical Data Presented at the 2020 San Antonio Breast Cancer Symposium VERU-111 has Anticancer Activity in Both Paclitaxel Sensitive and Paclitaxel Resistant Triple Negative Breast Cancer Tumors Veru Plans to Meet with FDA and Advance VERU-111 into a Phase 2b Clinical Trial in Women with Paclitaxel Resistant Triple Negative Breast Cancer in 2021
MIAMI, Dec. 14, 2020 (GLOBE NEWSWIRE) Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announces the presentation of preclinical data demonstrating the efficacy of oral VERU-111 in the treatment of human derived animal models of triple negative breast cancer at the 2020 San Antonio Breast Cancer Symposium.